APA (7th ed.) Citation

Lin, Y., Tseng, I., Kuo, C., Lin, H., Chiu, I., & Chiu, H. (2018). High‐level expression of ARID1A predicts a favourable outcome in triple‐negative breast cancer patients receiving paclitaxel‐based chemotherapy. Journal of cellular and molecular medicine, 22(4), 2458-2468. https://doi.org/10.1111/jcmm.13551

Chicago Style (17th ed.) Citation

Lin, Yuan‐Feng, Ing‐Jy Tseng, Chih‐Jung Kuo, Hui‐Yu Lin, I‐Jen Chiu, and Hui‐Wen Chiu. "High‐level Expression of ARID1A Predicts a Favourable Outcome in Triple‐negative Breast Cancer Patients Receiving Paclitaxel‐based Chemotherapy." Journal of Cellular and Molecular Medicine 22, no. 4 (2018): 2458-2468. https://doi.org/10.1111/jcmm.13551.

MLA (9th ed.) Citation

Lin, Yuan‐Feng, et al. "High‐level Expression of ARID1A Predicts a Favourable Outcome in Triple‐negative Breast Cancer Patients Receiving Paclitaxel‐based Chemotherapy." Journal of Cellular and Molecular Medicine, vol. 22, no. 4, 2018, pp. 2458-2468, https://doi.org/10.1111/jcmm.13551.